|
1
|
Nash K, Hafeez A and Hou S:
Hospital-acquired renal insufficiency. Am J Kidney Dis. 39:930–936.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsai TT, Patel UD, Chang TI, Kennedy KF,
Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC,
Rumsfeld JS and Spertus JA: Contemporary incidence, predictors, and
outcomes of acute kidney injury in patients undergoing percutaneous
coronary interventions: Insights from the NCDR Cath-PCI registry.
JACC Cardiovasc Interv. 7:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hernandez GT and Nasri H: World Kidney Day
2014: Increasing awareness of chronic kidney disease and aging. J
Renal Inj Prev. 3:3–4. 2014.PubMed/NCBI
|
|
4
|
Nicola R, Shaqdan KW, Aran K, Mansouri M,
Singh A and Abujudeh HH: Contrast-induced nephropathy: Identifying
the risks, choosing the right agent and reviewing effective
prevention and management methods. Curr Probl Diagn Radiol.
44:501–504. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perrin T, Descombes E and Cook S:
Contrast-induced nephropathy in invasive cardiology. Swiss Med
Wkly. 142:w136082012.PubMed/NCBI
|
|
6
|
Schickel R, Boyerinas B, Park S and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schena FP, Serino G and Sallustio F:
MicroRNAs in kidney diseases: New promising biomarkers for
diagnosis and monitoring. Nephrol Dial Transpl. 29:755–763. 2014.
View Article : Google Scholar
|
|
8
|
Du J, Cao X, Zou L, Chen Y, Guo J, Chen Z,
Hu S and Zheng Z: MicroRNA-21 and risk of severe acute kidney
injury and poor outcomes after adult cardiac surgery. PLoS One.
8:e633902013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shapiro MD, Bagley J, Latz J, Godwin JG,
Ge X, Tullius SG and Iacomini J: MicroRNA expression data reveals a
signature of kidney damage following ischemia reperfusion injury.
PLoS One. 6:e230112011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pavkovic M, Riefke B and
Ellinger-Ziegelbauer H: Urinary microRNA profiling for
identification of biomarkers after cisplatin-induced kidney injury.
Toxicology. 324:147–157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li YF, Jing Y, Hao J, Frankfort NC, Zhou
X, Shen B, Liu X, Wang L and Li R: MicroRNA-21 in the pathogenesis
of acute kidney injury. Protein Cell. 4:813–819. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Godwin JG, Ge X, Stephan K, Jurisch A,
Tullius SG and Iacomini J: Identification of a microRNA signature
of renal ischemia reperfusion injury. Proc Natl Acad Sci USA.
107:14339–14344. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kaucsár T, Révész C, Godó M, Krenács T,
Albert M, Szalay CI, Rosivall L, Benyó Z, Bátkai S, Thum T, et al:
Activation of the miR-17 Family and miR-21 During murine kidney
ischemia-reperfusion injury. Nucleic Acid Ther. 23:344–354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saikumar J, Hoffmann D, Kim TM, Gonzalez
VR, Zhang Q, Goering PL, Brown RP, Bijol V, Park PJ, Waikar SS and
Vaidya VS: Expression, circulation, and excretion profile of
MicroRNA-21, −155 and −18a following acute kidney injury. Toxicol
Sci. 129:256–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanki M, Moriguchi A, Sasaki D, Mitori H,
Yamada A, Unami A and Miyamae Y: Identification of urinary miRNA
biomarkers for detecting cisplatin-induced proximal tubular injury
in rats. Toxicology. 324:158–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Allgayer H: Pdcd4, a colon cancer
prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol.
73:185–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aurelio A and Durante A: Contrast-induced
nephropathy in percutaneous coronary interventions: Pathogenesis,
risk factors, outcome, prevention and treatment. Cardiology.
128:62–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Duarte CG and Ellis S: Contrast
medium- and mannitol-induced apoptosis in heart and kidney of SHR
rats. Toxicol Pathol. 27:427–435. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Romano G, Briguori C, Quintavalle C, Zanca
C, Rivera NV, Colombo A and Condorelli G: Contrast agents and renal
cell apoptosis. Eur Heart J. 29:2569–2576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Borkan SC: The Role of BCL-2 Family
Members in Acute Kidney Injury. Semin Nephrol. 36:237–250. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Havasi A and Borkan SC: Apoptosis and
acute kidney injury. Kidney Int. 80:29–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chandrasekaran K, Karolina DS, Sepramaniam
S, Armugam A, Wintour EM, Bertram JF and Jeyaseelan K: Role of
microRNAs in kidney homeostasis and disease. Kidney Int.
81:617–627. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lai JY, Luo J, O'Connor C, Jing X, Nair V,
Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D, et al:
MicroRNA-21 in Glomerular Injury. J Am Soc Nephrol. 26:805–816.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu X, Kriegel AJ, Liu Y, Usa K, Mladinov
D, Liu H, Fang Y, Ding X and Liang M: Delayed ischemic
preconditioning contributes to renal protection by upregulation of
miR-21. Kidney Int. 82:1167–1175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramachandran K, Saikumar J, Bijol V,
Koyner JL, Qian J, Betensky RA, Waikar SS and Vaidya VS: Human
miRNome Profiling Identifies MicroRNAs Differentially Present in
the Urine after Kidney Injury. Clin Chem. 59:1742–1752. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang W and Shu L: Upregulation of miR-21
by Ghrelin ameliorates ischemia/reperfusion-induced acute kidney
injury by inhibiting inflammation and cell apoptosis. DNA Cell
Biol. 35:417–425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gutiérrez-Escolano A, Santacruz-Vázquez E
and Gómez-Pérez F: Dysregulated microRNAs involved in
contrast-induced acute kidney injury in rat and human. Ren Fail.
37:1498–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Humphreys BD, Czerniak S, DiRocco DP,
Hasnain W, Cheema R and Bonventre JV: Repair of injured proximal
tubule does not involve specialized progenitors. Proc Natl Acad Sci
USA. 108:9226–9231. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun SQ, Zhang T, Ding D, Zhang WF, Wang
XL, Sun Z, Hu LH, Qin SY, Shen LH and He B: Circulating
MicroRNA-188, −30a, and −30e as early biomarkers for
contrast-induced acute kidney injury. J Am Heart Assoc. 5(pii):
e0041382016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Geenen RW, Kingma HJ and van der Molen AJ:
Contrast-induced nephropathy: pharmacology, pathophysiology and
prevention. Insights Imaging. 4:811–820. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tervahartiala P, Kivisaari L, Kivisaari R,
Vehmas T and Virtanen I: Structural changes in the renal proximal
tubular cells induced by iodinated contrast media. Nephron.
76:96–102. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hirsch R, Dent C, Pfriem H, Allen J,
Beekman RH III, Ma Q, Dastrala S, Bennett M, Mitsnefes M and
Devarajan P: NGAL is an early predictive biomarker of
contrast-induced nephropathy in children. Pediatr Nephrol.
22:2089–2095. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jia P, Teng J, Zou J, Fang Y, Zhang X,
Bosnjak ZJ, Liang M and Ding X: miR-21 contributes to
xenon-conferred amelioration of renal ischemia-reperfusion injury
in mice. Anesthesiology. 119:621–630. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu X, Hong Q, Wang Z, Yu Y, Zou X and Xu
L: MiR-21 inhibits autophagy by targeting Rab11a in renal
ischemia/reperfusion. Exp Cell Res. 338:64–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhong X, Chung AC, Chen HY, Dong Y, Meng
XM, Li R, Yang W, Hou FF and Lan HY: miR-21 is a key therapeutic
target for renal injury in a mouse model of type 2 diabetes.
Diabetologia. 56:663–674. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chau BN, Xin C, Hartner J, Ren S, Castano
AP, Linn G, Li J, Tran PT, Kaimal V, Huang X, et al: MicroRNA-21
promotes fibrosis of the kidney by silencing metabolic pathways.
Sci Transl Med. 4:118ra–121ra. 2012. View Article : Google Scholar
|
|
38
|
Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and
Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation,
invasion, migration, and apoptosis by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One.
9:e1036982014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2007. View Article : Google Scholar : PubMed/NCBI
|
